<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="has been synthesised and evaluated for their effect on human" exact="lung cancer" post="cell line (A549), human colorectal cancer cell line (HCT116)"/>
 <result pre="been synthesised and evaluated for their effect on human lung" exact="cancer" post="cell line (A549), human colorectal cancer cell line (HCT116)"/>
 <result pre="their effect on human lung cancer cell line (A549), human" exact="colorectal cancer" post="cell line (HCT116) and HDAC isoforms 1, 2, 6,"/>
 <result pre="effect on human lung cancer cell line (A549), human colorectal" exact="cancer" post="cell line (HCT116) and HDAC isoforms 1, 2, 6,"/>
 <result pre="population in sub G1 phase. Graphical Abstract Keywords Quinoline HDAC" exact="lung cancer" post="colon cancer hydroxamic acid acrylamide fig-count: table-count: page-count: word-count:"/>
 <result pre="in sub G1 phase. Graphical Abstract Keywords Quinoline HDAC lung" exact="cancer" post="colon cancer hydroxamic acid acrylamide fig-count: table-count: page-count: word-count:"/>
 <result pre="sub G1 phase. Graphical Abstract Keywords Quinoline HDAC lung cancer" exact="colon cancer" post="hydroxamic acid acrylamide fig-count: table-count: page-count: word-count: 1. Introduction"/>
 <result pre="G1 phase. Graphical Abstract Keywords Quinoline HDAC lung cancer colon" exact="cancer" post="hydroxamic acid acrylamide fig-count: table-count: page-count: word-count: 1. Introduction"/>
 <result pre="have emerged as a potential target for the treatment of" exact="cancer" post="and various other physiological disorders. Gene expression regulation by"/>
 <result pre="(13), a selective HDAC6 inhibitor which exhibits potent activity against" exact="multiple myeloma" post="(Figure 2)28,29. Continuing our efforts on investigation of quinoline-containing"/>
 <result pre="1.61â€‰ÂµM, respectively. Table 1. Antiproliferative activity (IC50, Î¼M) against human" exact="cancer" post="cell lines by compounds 14â€&quot;29 Â Cell lines Compd"/>
 <result pre="= 31.49). 4.2. Biology 4.2.1. Tumour cell culture All human" exact="cancer" post="cells were maintained in RPMI 1640 medium supplemented with"/>
 <result pre="Eur J Med Chem2020;185:111725.31655430 7CeccacciE, MinucciS.Inhibition of histone deacetylases in" exact="cancer" post="therapy: lessons from leukaemia. Br J Cancer2016;114:605â€&quot;11.26908329 8(a) MehndirattaS,"/>
 <result pre="Chem2020;11:969â€&quot;81.(b) QuintÃ¡s-CardamaA, SantosFPS, Garcia-ManeroG.Histone deacetylase inhibitors for the treatment of" exact="myelodysplastic syndrome" post="and acute myeloid leukemia. Leukemia2011;25:226â€&quot;35.21116282 9MehndirattaS, HsiehYL, LiuYM, et"/>
 <result pre="Garcia-ManeroG.Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and" exact="acute myeloid leukemia." post="Leukemia2011;25:226â€&quot;35.21116282 9MehndirattaS, HsiehYL, LiuYM, et al.Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase"/>
 <result pre="deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute" exact="myeloid leukemia." post="Leukemia2011;25:226â€&quot;35.21116282 9MehndirattaS, HsiehYL, LiuYM, et al.Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase"/>
 <result pre="histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via" exact="suppression" post="of cytokines. Proc Natl Acad Sci2002;99:2995â€&quot;3000.11867742 11DinarelloCA.Anti-inflammatory agents: present"/>
 <result pre="OhSW, KangMS, et al.Trichostatin A attenuates airway inflammation in mouse" exact="asthma" post="model. Clin Exper Allergy2005;35:89â€&quot;96.15649272 13NasuY, NishidaK, MiyazawaS, et al.Trichostatin"/>
 <result pre="synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced" exact="arthritis" post="mouse model. Osteoarthr Cartil2008;16:723â€&quot;32. 14ChooQY, HoPC, TanakaY, et al.Histone"/>
 <result pre="arrest and suppressed lipopolysaccharide-stimulated NF-ÎºB p65 nuclear accumulation in human" exact="rheumatoid arthritis" post="synovial fibroblastic E11 cells. Rheumatology2010;49:1447â€&quot;60.20421217 15ZhangZ, ZhangZ, SchluesenerH.MS-275 a"/>
 <result pre="and suppressed lipopolysaccharide-stimulated NF-ÎºB p65 nuclear accumulation in human rheumatoid" exact="arthritis" post="synovial fibroblastic E11 cells. Rheumatology2010;49:1447â€&quot;60.20421217 15ZhangZ, ZhangZ, SchluesenerH.MS-275 a"/>
 <result pre="of MPT0E028, a novel potent histone deacetylase inhibitor, in human" exact="colorectal cancer" post="HCT116 cells inÂ vitro and inÂ vivo. PLoS ONE2012;8:e43645."/>
 <result pre="MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal" exact="cancer" post="HCT116 cells inÂ vitro and inÂ vivo. PLoS ONE2012;8:e43645."/>
 <result pre="al.(N-Hydroxycarbonylbenylamino)quinolines as selective histone deacetylase 6 inhibitors suppress growth of" exact="multiple myeloma" post="inÂ vitro and inÂ vivo. J Med Chem2018;61:905â€&quot;17.29304284 29TuHJ,"/>
 <result pre="a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human" exact="acute leukemia" post="cells. Clin Epigenetics2018;10:162.30594243"/>
 <result pre="novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute" exact="leukemia" post="cells. Clin Epigenetics2018;10:162.30594243"/>
</results>
